glp-1/gip receptor agonists PDB-101: Molecule of the Month: GLP-1 GLP-1 & GIP Agonists |
Description
When should you seek extra support
Diabetes 60, 12701276 (2011)
A 2025 analysis found that GLP-1 agonists given for diabetes were associated with a reduced risk of substance use among hundreds of thousands of United States Veterans and a 2024 examination of over 500k patients 4 Qeadan, F., McCunn, A., & Tingey, B
High sugar intake can blunt natural GLP-1 secretion and worsen insulin resistance
Real-world evidence can show payers which subpopulations benefit most and inform more equitable coverage policies
